Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

288 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 288 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02657551
What this trial is testing

A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Early research (Phase 1)Not Yet RecruitingNCT06283134
What this trial is testing

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
China Medical University, China 60
Testing effectiveness (Phase 2)UnknownNCT05485909
What this trial is testing

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Who this might be right for
Colorectal Cancer Liver Metastases
Sun Yat-sen University 32
Early research (Phase 1)Active Not RecruitingNCT05830084
What this trial is testing

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Gustave Roussy, Cancer Campus, Grand Paris 23
Not applicableStudy completedNCT05839951
What this trial is testing

An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Bayer 818
Early research (Phase 1)Study completedNCT02001909
What this trial is testing

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Who this might be right for
Neoplasms
Bayer 27
Testing effectiveness (Phase 2)UnknownNCT05134532
What this trial is testing

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
CHA University 40
Not applicableUnknownNCT05811481
What this trial is testing

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib
WenBo Guo 192
Not applicableStudy completedNCT05759195
What this trial is testing

Biomolecular Analysis for Predicting Response to Regorafenib

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 53
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Testing effectiveness (Phase 2)Study completedNCT02307500
What this trial is testing

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

Who this might be right for
Pancreas CancerOvarian CancerMelanoma+4 more
Istituto Clinico Humanitas 82
Testing effectiveness (Phase 2)Study completedNCT04310709
What this trial is testing

Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularHepatoma
Asan Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT02788006
What this trial is testing

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

Who this might be right for
Colorectal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 43
Testing effectiveness (Phase 2)Looking for participantsNCT06099821
What this trial is testing

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Who this might be right for
Digestive System Cancers
Peking University Cancer Hospital & Institute 39
Large-scale testing (Phase 3)Study completedNCT03465722
What this trial is testing

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation 476
Testing effectiveness (Phase 2)Active Not RecruitingNCT04803877
What this trial is testing

SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in ChildrenOsteosarcoma Recurrent+1 more
Sarcoma Alliance for Research through Collaboration 48
Testing effectiveness (Phase 2)Study completedNCT02459119
What this trial is testing

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Who this might be right for
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
University of Alabama at Birmingham 17
Early research (Phase 1)Study completedNCT01287598
What this trial is testing

BAY73-4506 Probe Substrate Study

Who this might be right for
Neoplasms
Bayer 41
Load More Results